结论静脉应用胺碘酮治疗急性冠脉综合征并发快速房颤，是一种安全、有效的临床措施。
Conclusion Intravenous amiodarone is a safe and effective clinic measure to fast atrial fibrillation patients with ACS.
目的：探讨不同剂量辛伐他汀早期治疗急性冠脉综合征(ACS)脂代谢紊乱的调脂疗效及达标率。
Objective: This study is designed to evaluate the efficacy and safety of different dosage simvastatin on the acute coronary syndrome (ACS) patients with lipid disorders after short time medication.
急性冠脉综合征在及时的早期诊断后是可治疗的，根据症状、体征和全身健康状况，其治疗方法各异。
Acute coronary syndrome is treatable if diagnosed quickly. Acute coronary syndrome treatments vary, depending on your signs, symptoms and overall health condition.
目的研究健康教育预防急性冠脉综合征(ACS)的临床治疗效果。
Objective To observe the therapeutic effect of individual health education in preventing acute coronary arteries syndrome (ACS).
目的：观察胰岛素对患有急性冠脉综合征的非糖尿病患者高血糖的治疗效果。
Objective: To determine the effect of insulin for the management of hyperglycaemia in non-diabetic patients presenting with acute coronary syndrome.
研究者检查了治疗实验中681名无st段抬高的急性冠脉综合征病人的GRACE危险分数。
The researchers determined the GRACE risk score in 681 non-ST-elevation ACS patients enrolled in a treatment trial.
介绍了老年急性冠脉综合征临床特征、治疗。
It introduced the clinical characteristics and therapy of senile acute coronary syndrome.
背景合并2型糖尿病的非st段抬高的急性冠脉综合征病人，无论用当前任何治疗方法，都有较高的大血管事件发生率。
Background Despite current treatment, patients who have acute coronary syndromes without ST-segment elevation associated with t 2 Diabetes have high rates of major vascular events.
目的：本研究旨在探索阿托伐他汀对急性冠脉综合征(ACS)患者行经皮冠脉介入治疗(pci)潜在的保护作用。
Objectives: This study sought to investigate potential protective effects of atorvastatin in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI).
在中国，超过80%急性冠脉综合征的患者介入治疗过程中选择des，您如何看待？
You know, in China, there are more than 80% ACS patients implanted with DES if they are performed PCI. What do you think about it?
目的：探讨血府逐瘀汤治疗非ST段抬高型急性冠脉综合征（NEST-ACS）的临床疗效及其对炎症因子的影响。
Objective:To investigate the Xuefu Zhuyu Tang(XZT) treatment of non-ST segment elevation Acute Coronary Syndrome(NEST-ACS) and its impact on the effects of Inflammatory factors.
目的：本研究旨在探讨90岁以上非st段抬高急性冠脉综合征(NSTE - ACS)患者的治疗措施及预后。
Objectives: the goal of this work was to explore the treatment and outcomes of patients with non-st-segment elevation acute coronary syndromes (NSTE-ACS) age 90 years.
目的探讨65岁以上急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(pci)的临床疗效。
Objectives To explore the clinical effects of percutaneous coronary interventions (PCI) on elderly patients with acute coronary syndrome (ACS) who were all more than 65 years old.
充血性心力衰竭诊断、治疗、预后，急性冠脉综合征患者的危险分层，都与血脑钠肽水平升高有着密切的关系。
The diagnosis, treatment, and prognosis of congestive heart failure, and the risk stratification of patients with acute coronary syndrome, have close ties with elevated blood levels of BNP.
目的：探讨急性冠脉综合征患者应用阿托伐他汀调脂治疗后对血管内皮舒张功能、血浆纤溶酶原激活物抑制物1及血管内皮素1的影响。
Objective To study the effects of atorvastatin cholesterol-lowering therapy on vascular endothelial function and plasminogen activator inhibitor-1 in acute coronary syndromes.
氯吡格雷是一种抗血小板药物，是新型二磷酸腺苷受体拮抗剂，已广泛应用于急性冠脉综合征和经皮冠状动脉介入治疗的抗血栓治疗。
Clopidogrel is a kind of drug to resistant platelet, it is a new ADP receptor resistant. It has been used in acute coronary syndrome and percutaneous coronary intervention patients widely.
结论PT CA组的治疗急诊老年急性冠脉综合征的疗效优于常规治疗组，值得急诊科推广。
Conclusion the curative effect of treatment elderly acute coronary syndrome emergency, the PTCA group is superior to the control group and is worth the emergency department promotion.
本文阐述了预防急性冠脉综合征的治疗进展及护理对策。
This article summarized the prevention and treatment progress on ACS a...
结论磺达肝癸钠治疗非st段抬高急性冠脉综合征安全有效。
ConclusionFondaparinux Na was a safe and effective treatment for NSTEMI.
结论磺达肝癸钠治疗非st段抬高急性冠脉综合征安全有效。
ConclusionFondaparinux Na was a safe and effective treatment for NSTEMI.
应用推荐